Lentitek
Signal active
Organization
Contact Information
Overview
Lentitek is a cell and gene therapy company that is finding solutions to make exceptional cures available to more people. Lentitek is working on strategies to increase viral yield by tenfold or more.
About
Industries
Biotechnology, Health Care, Medical
Founded
2019
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Lentitek headquartered in Europe, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $3.7M in funding across 12 round(s). With a team of 1-10 employees, Lentitek is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Lentitek, raised $310.3K. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
4
Lead Investors
0
Total Funding Amount
$310.3K
Details
1
Lentitek has raised a total of $310.3K in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 310.3K |
Investors
Lentitek is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Apollo Informal Investment | - | FUNDING ROUND - Apollo Informal Investment | 310.3K |
| University of Edinburgh | - | FUNDING ROUND - University of Edinburgh | 310.3K |
| Lentitek | - | FUNDING ROUND - Lentitek | 310.3K |
| Gillian MacAulay | - | FUNDING ROUND - Gillian MacAulay | 310.3K |
Recent Activity
There is no recent news or activity for this profile.